IGI Logo
Toggle Navigation
News
Hindi
Hindi News
Top News
Screeners
Stocks
Stocks Screener
Stock
News
Stock Market Home Page
Stock News
Industry News
Economy News
Stock on the move
Expert Views
Research Reports
Company Result
Comp Info And Fundamentals
Company Profile
Equity
Financial Ratios
Results
Balance Sheet
Profit And Loss
Cash Flow
Share Holding
Derivatives (F&O)
Get Quotes
Market Watch
Top Gainers
Top Losers
Top Traded Quantity
Top Traded Value
Most Active Puts
Derivatives (F&O)
Most Active Calls
Put Call Ratio
Highest In Premium
Daily Settlement Price
FII and DII Statistics
Open Interest: Highest In OI
Open Interest: Lowest In OI
Derivatives (F&O)
Open Interest: Increase in OI Increase in Price
Open Interest: Decline in OI Decrease in Price
Derivative Watch
Derivatives Dashboard
Historical Data
List of Underlyings & Underlying Info
Derivative Watch
Derivatives Dashboard
Market Reports
Top Gainers
Top Losers
Monthly High/Low
52 Week High
52 Week Low
Market Cap Gainers
Market Cap Losers
PE Ratio
>More Market Reports
IPO
News
IPO News
IPO Issue Reports
Commodity
Commodity Market
Commodity Home Page
Commodity News
Commodity Reports
Market Details
Get Quotes
Top Gainers
Top Losers
Top Volume
Top Value
Top Gainers Spot Market
Top Losers Spot Market
High & Low
Commodity Indices
Technical Analysis
Advance Declines
High & Low
Highest In OI
Lowest OI
Increase In Open Interest(%)
Descrease In Open Interest(%)
Currency
News
Currency News
Economy News
Currency Reports
Mutual Fund
News
Mutual Fund Home Page
Mutual Fund News
Mutual Fund Details
Mutual Fund Home Page
Compare Scheme
Scheme Profile
Mutual fund Investment
Mutual Fund Share Holding
Mutual Fund Statistics
Mutual fund Gainers
Mutual fund Losers
Biggest Schemes
Best Performers
Latest Dividend Details
Tools
Multi Scheme Comparison Tool
Dividend Details
Performance Map
Mutual fund Investment
Mutual fund Share Holding
Mutual Fund Search Category Rankings
Widgets
Stock Widgets
Watchlist
Heatmap
Mutual Fund Widgets
Watchlist
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
Wealth
World
Tips
Intraday Tips
Market Outlook
Stock Tips
Commodity Tips
Currency Tips
Reports
Short Term Investment Opportunities
Long Term Investment Opportunities
Sector Analysis
Commodity Reports
Currency Reports
Mutual Fund Analysis
Podcast
Videos
Videos Category
Business Videos
Budget Videos
News And Politics
Entertainment Videos
Sports Videos
Lifestyle And Fashion Videos
Global News Videos
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
More
Budget 2024
Astrology
Women
Politics
Entertainment
Car&Bike
Gadgets
Lifestyle
Sports
Health
Fashion
Diwali Reports
Diwali Expert Reports
News
Astrology
Beyond Market Car
Beyond Market Entertainment
Beyond Market Fashion
Beyond Market Gadgets
Beyond Market Health
Beyond Market India
Beyond Market Life Style
Beyond Market Sports
Broking Firm Views
Broking Firm Views - Long Term Report
Broking Firm Views - Sector Report
Broking Firm Views - Short Term Report
Budget 2024 Sector Reports
Budget Bites
Budget Economic Servey
Budget Expert Views
Budget Industry
Budget News
Budget Wishlist
Commodities
Commodities Reports
Commodity Top News
Company News
Company Result
Currency News
Currency Report
Currency Top News
Diwali Expert Views
Diwali Market Outlook
Diwali Report
Diwali Technical Report
Economy News
Expert View Institution
Expert Views
Industry News
IPO Analysis
IPO More News
IPO Reports
IPO Top News
Market Outlook
Mutual Fund Analysis
Mutual Fund Expert Views
Mutual Fund More News
Mutual Fund Top News
Podcast - Market Ki Awaaz
Special Event Expert Views
Special Event Reports
Startup
Startup Expections
Startup Speak
Stock Market
Stock On The Move
Top News
Top Stories
Videos
Videos Business
Videos Entertainment
Videos Global News
Videos Lifestyle And Fashion
Videos News And Politics
Videos Sports
Wealth
Women
World Market More News
World Top News
Search
Glenmark Pharmaceuticals Ltd * Pharma index has been maintaining its positive tone and Glenmark is trading in sync. * It has witnessed a fresh breakout above its rising trend line indicating continuation of trend. * Technical indicators and volumes addition suggests the trend likely to continue with certainty of further follow-on * Traders are recommended to participate in the move with positive bias within the said range. Buy Glenmark Pharmaceutica...
Stock of the day : Glenmark Pharmaceuticals Ltd For Target Rs. 1944 - Religare Broking
Glenmark Pharmaceuticals Ltd Buy Glenmark Pharmaceuticals Ltd @ 1730-1732 Target 1750.00 Stop Loss 1721.80 Hindustan Petroleum Corporation Ltd Buy Hindustan Petroleum Corporation Ltd @ 389-390 Target 394.50 Stop Loss 387.20 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Glenmark Pharmaceuticals Ltd And Hindustan Petroleum Corporation Ltd By ICICI Direct
Operationally in-line 1Q; DF/EU drive earnings Growth levers across key markets * Glenmark Pharma (GNP) delivered an in-line operating performance in 1QFY25. It witnessed robust traction in the domestic formulation (DF) and Europe businesses. However, this was partly offset by muted show in US/ROW markets. * We raise our earnings estimates by 11%/17% for FY25/FY26, factoring in a) the niche product pipeline in respiratory for US generics, b) outperformance vs. the industry in DF seg...
Buy Glenmark Pharma Ltd For Target Rs.1,850 By Motilal Oswal Financial Services Ltd
Glenmark Pharmaceuticals is currently trading at Rs. 1595.00, up by 30.30 points or 1.94% from its previous closing of Rs. 1564.70 on the BSE. The scrip opened at Rs. 1573.45 and has touched a high and low of Rs. 1602.15 and Rs. 1567.15 respectively. So far 8097 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1,610.00 on 19-Aug-2024 and a 52 week low of Rs. 702.05 on 12-Nov-2023. Last one week high and low of th...
Glenmark Pharmaceuticals surges as its arm launches Olopatadine Hydrochloride Ophthalmic Solution USP
Glenmark Pharmaceuticals is currently trading at Rs. 1560.95, up by 69.95 points or 4.69% from its previous closing of Rs. 1491.00 on the BSE. The scrip opened at Rs. 1518.70 and has touched a high and low of Rs. 1576.65 and Rs. 1427.35 respectively. So far 145427 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1576.65 on 16-Aug-2024 and a 52 week low of Rs. 702.05 on 12-Nov-2023. Last one week high and low of t...
Glenmark Pharmaceuticals shines on reporting 9-fold jump in Q1 consolidated net profit
Glenmark Pharmaceuticals on Wednesday reported a more than two-fold jump in its net profit to Rs 462 crore for the April-June quarter of the current financial year compared to the corresponding figure of Rs 203 crore in the same quarter of the previous year. The increase in profit came on the back of a strong demand for the company's medicines, while there was a marginal decline of 1.4 per cent in costs as well. The Mumbai-headquartered pharma major's revenue from o...
Glenmark Pharma clocks 2-fold jump in Q1 net profit at Rs 462 crore
Glenmark Pharmaceuticals is currently trading at Rs. 1417.15, up by 6.65 points or 0.47% from its previous closing of Rs. 1410.50 on the BSE. The scrip opened at Rs. 1429.95 and has touched a high and low of Rs. 1429.95 and Rs. 1413.35 respectively. So far 1924 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1426.70 on 16-Jul-2024 and a 52 week low of Rs. 695.55 on 17-Jul-2023. Last one week high and low of the ...
Glenmark Pharmaceuticals gains on getting final approval for Topiramate Capsules
Glenmark Pharmaceuticals is currently trading at Rs. 1197.90, up by 6.40 points or 0.54% from its previous closing of Rs. 1191.50 on the BSE. The scrip opened at Rs. 1198.60 and has touched a high and low of Rs. 1203.25 and Rs. 1189.15 respectively. So far 1609 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1218.00 on 06-Jun-2024 and a 52 week low of Rs. 620.05 on 23-Jun-2023. Last one week high and low of the ...
Glenmark moves up as its arm gets USFDA`s approval for Esomeprazole Magnesium Delayed-Release Capsules
India business re-set drags earnings Work-in progress to address the USFDA issues * Glenmark Pharma (GNP) delivered a miss on its 3QFY24 earnings, largely due to the inventory reset in the domestic formulation (DF) business and an inferior show in the US generics segment. GNP has completed its remediation measures at Monroe and would be requesting the USFDA for a re-inspection. * We cut our FY24/FY25/FY26 estimates by 94%/4%/4% to factor in: a) the significant reduction in the domes...
Neutral Glenmark Pharma Ltd For Target Rs.820 - Motilal Oswal Financial Services
Glenmark Pharmaceuticals is currently trading at Rs. 1009.80, up by 3.65 points or 0.36% from its previous closing of Rs. 1006.15 on the BSE. The scrip opened at Rs. 1006.20 and has touched a high and low of Rs. 1020.45 and Rs. 1005.70 respectively. So far 678 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1098.00 on 29-Apr-2024 and a 52 week low of Rs. 581.20 on 22-May-2023. Last one week high and low of the s...
Glenmark inches up on getting USFDA`s final approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
Glenmark Pharmaceuticals is currently trading at Rs. 1088.25, up by 8.20 points or 0.76% from its previous closing of Rs. 1080.05 on the BSE. The scrip opened at Rs. 1092.60 and has touched a high and low of Rs. 1092.60 and Rs. 1085.60 respectively. So far 578 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1095.95 on 25-Apr-2024 and a 52 week low of Rs. 535.15 on 3-May-2023. Last one week high and low of the sc...
Glenmark Pharmaceuticals moves up on getting USFDA`s final approval for Acetaminophen and Ibuprofen Tablets
Glenmark Pharmaceuticals Ltd * We are seeing decent traction in the pharma space and Glenmark offering fresh buying opportunity. * It has recorded a decisive breakout from the channel pattern which continued for over 5 months. * Following price action and buoyancy in the pharma sector suggests bullish tone to continue. * We thus recommend creating fresh longs in the mentioned range. Buy Glenmark Pharmaceuticals Ltd CMP 955.25; Range 954-956; SL 925; Target 10...
Stock of the day : Glenmark Pharmaceuticals Ltd For Target Rs. 1015 - Religare Broking
India business re-set drags earnings Work-in progress to address the USFDA issues * Glenmark Pharma (GNP) delivered a miss on its 3QFY24 earnings, largely due to the inventory reset in the domestic formulation (DF) business and an inferior show in the US generics segment. GNP has completed its remediation measures at Monroe and would be requesting the USFDA for a re-inspection. We cut our FY24/FY25/FY26 estimates by 94%/4%/4% to factor in: a) the significant reduction in the domestic fo...
Neutral Glenmark Pharma Ltd For Target Rs. 820 - Motilal Oswal Financial Services Ltd
Pfizer and Glenmark Pharmaceuticals Ltd. (Glenmark) have joined hands to launch abrocitinib, a first of its kind oral advanced systemic treatment for moderate-to-severe atopic dermatitis (AD), in India. Developed by Pfizer, abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India and is approved by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory agencies. When launched in India,...
Glenmark partners with Pfizer to launch Abrocitinib in India
Glenmark Pharmaceuticals Ltd * Pharma sector witnessing consistent buying interest and Glenmark is trading insync. * It has formed a fresh buying pivot holding above its short term moving and its prior resistance zone. * Following price action and uptick is volume, we believe prevailing trend to strengthen further. * We thus recommend creating fresh longs in the mentioned range. BUY Glenmark Ltd CMP 910.20; Range 908-912; SL884; Target 965 &...
Stock of the day : Glenmark Ltd For Target Rs.965 - Religare Broking
Glenmark Pharmaceuticals is currently trading at Rs. 903.75, up by 12.90 points or 1.45% from its previous closing of Rs. 890.85 on the BSE. The scrip opened at Rs. 890.85 and has touched a high and low of Rs. 906.50 and Rs. 889.75 respectively. So far 3133 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 915.95 on 15-Jan-2024 and a 52 week low of Rs. 369.50 on 30-Jan-2023. Last one week high and low of the scrip...
Glenmark Pharmaceuticals rises as its arm signs license agreement with Jiangsu Alphamab, 3DMed
Glenmark Pharmaceuticals Ltd * Pharma sector witnessing consistent buying interest and Glenmark with in the space offering fresh buying opportunity. * It has witnessed a fresh breakout from the consolidation range which continued for more than four months. * The uptick in volumes and positive positioning of momentum indicator suggests bullish tone to continue. * We thus recommend creating fresh longs in the mentioned range. Buy Glenmark Pharmaceuticals Ltd CMP 888.80;&...
Stock of the day : Glenmark Pharmaceuticals Ltd For Target Rs. 950 - Religare Broking
Glenmark Pharmaceuticals is currently trading at Rs. 896.20, up by 8.05 points or 0.91 % from its previous closing of Rs. 888.15 on the BSE. The scrip opened at Rs. 898.85 and has touched a high and low of Rs. 898.85 and Rs. 892.05 respectively. So far 3031 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 901.45 on 02-Jan-2024 and a 52 week low of Rs. 369.50 on 30-Jan-2023. Last one week high and low of the scrip...
Glenmark Pharmaceuticals gains on launching biosimilar of popular anti-diabetic drug Liraglutide in India
Wipro Ltd Buy Wipro Ltd @418-419; Target 424.00; Stop Loss 415.80 Glenmark Ltd Buy Glenmark Ltd @821-822; Target 829.80; Stop Loss 816.40 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Wipro Ltd And Glenmark Ltd By ICICI Direct
GLENMARK Ltd * We are seeing decent traction in selective pharma pack and Glenmark is trading insync. * Rebounded higher finding support around the lower end of the range which coincides with 100 DEMA. * Price action combined with buoyancy in the pharma pack is pointing towards breakout. * We thus recommend creating fresh longs in the mentioned zone. Buy GLENMARK Ltd CMP 821.90; Range* 821-823 ; SL 795; Target 870 Please refer disclaimer at https...
Stock of the day : Buy Glenmark Ltd For Target Rs.870- Religare Broking
Glenmark Pharmaceuticals is currently trading at Rs. 728.50, down by 34.70 points or 4.55% from its previous closing of Rs. 763.20 on the BSE. The scrip opened at Rs. 762.80 and has touched a high and low of Rs. 762.80 and Rs. 726.60 respectively. So far 127949 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 879.15 on 21-Sep-2023 and a 52 week low of Rs. 369.50 on 30-Jan-2023. Last one week high and low of the s...
Glenmark Pharmaceuticals falls on reporting consolidated net loss of Rs 62 crore in Q2FY24
India's generic drugmaker Glenmark Pharmaceuticals reported a loss in the second quarter, hurt by exceptional costs related to a legal settlement and higher expenses. The company posted a consolidated net loss, from continuing operations, of 2.01 billion rupees ($24.14 million) for the three months ended Sept. 30, from a profit of 1.54 billion rupees a year ago. Glenmark incurred an exceptional cost of 3.25 billion rupees, during the quarter, related to a legal case settlement with ...
India`s Glenmark Pharma posts Q2 loss on exceptional legal costs
Glenmark Pharmaceuticals is currently trading at Rs. 761.00, up by 5.40 points or 0.71% from its previous closing of Rs. 755.60 on the BSE. The scrip opened at Rs. 752.05 and has touched a high and low of Rs. 768.20 and Rs. 752.05 respectively. So far 3273 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 879.15 on 21-Sep-2023 and a 52 week low of Rs. 369.50 on 30-Jan-2023. Last one week high and low of the scrip ...
Glenmark Pharmaceuticals moves up on getting USFDA`s approval for Fluphenazine Hydrochloride Tablets
India's Glenmark Life Sciences reported an 11.1% rise in second-quarter profit on Friday, led by strong growth in its mainstay active pharmaceutical ingredients (API) business in domestic as well as U.S. and European markets.The Mumbai-based drugmaker said its profit rose to 1.19 billion rupees ($14.3 million) for the quarter ended Sept. 30, from 1.07 billion rupees a year earlier.The company, spun off from Glenmark Pharmaceuticals in 2019 to focus on the API business, said its revenue from o...
India`s Glenmark Life Sciences posts Q2 profit rise on API boost
Glenmark Pharmaceuticals is currently trading at Rs. 809.05, up by 7.60 points or 0.95% from its previous closing of Rs. 801.45 on the BSE.The scrip opened at Rs. 805.25 and has touched a high and low of Rs. 810.35 and Rs. 805.20 respectively. So far 3294 shares were traded on the counter.The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 879.15 on 21-Sep-2023 and a 52 week low of Rs. 369.50 on 30-Jan-2023.Last one week high and low of the scrip stood at Rs. 811.70 ...
Glenmark Pharmaceuticals moves up on launching Triple-drug FDC of Teneligliptin with Dapagliflozin and Metformin
Glenmark Pharmaceuticals is currently trading at Rs. 800.90, up by 3.40 points or 0.43% from its previous closing of Rs. 797.50 on the BSE.The scrip opened at Rs. 796.50 and has touched a high and low of Rs. 805.55 and Rs. 796.50 respectively. So far 3169 shares were traded on the counter.The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 879.15 on 21-Sep-2023 and a 52 week low of Rs. 369.50 on 30-Jan-2023.Last one week high and low of the scrip stood at Rs. 809.25 ...
Glenmark Pharmaceuticals inches up on getting final nod for Apremilast Tablets
Glenmark Pharmaceuticals is currently trading at Rs. 788.50, up by 7.95 points or 1.02% from its previous closing of Rs. 780.55 on the BSE.The scrip opened at Rs. 783.25 and has touched a high and low of Rs. 790.25 and Rs. 783.25 respectively. So far 6858 shares were traded on the counter.The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 879.15 on 21-Sep-2023 and a 52 week low of Rs. 369.50 on 30-Jan-2023.Last one week high and low of the scrip stood at Rs. 799.40 ...
Glenmark Pharmaceuticals rises as its arm signs agreement for OX40 antagonist monoclonal antibody portfolio
Earnings neutral event* Glenmark Pharma (GNP) has proposed to divest its API business, Glenmark Lifescience (GLS) with the aim of reducing debt and increasing its emphasis on branded/innovative products. * This is the third transaction by GNP with a cumulative cash generation of INR62.5b over the past 12-15M. * After the stake sale, GNP is set to transition from a net debt position of INR29.5b to a cash surplus INR21b. * The net reduction in overall EBITDA due to the sale of API busine...
Neutral Glenmark Pharmaceuticals For Target Rs. 780 - Motilal Oswal Financial Services
Glenmark Pharma will sell a 75% stake in its life sciences unit to detergent maker Nirma for 56.52 billion rupees ($679.84 million) and use the proceeds to repay debt, the company said on Thursday.The sale frees up Glenmark Pharma to focus on its business that sells branded drugs to treat skin and respiratory disorders, and invest in product development, as it eyes market expansion in Latin America, parts of Europe and India."Synergies between Glenmark Pharma and GLS business have been rapidl...
India`s Glenmark to sell majority stake in life sciences unit for $680 million
Glenmark Pharmaceuticals Ltd* We are seeing consistent buying in select pharma counters and Glenmark is trading in sync.* It has been in a steady uptrend from past more than nine months. * Witnessed a fresh breakout from a consolidation range indicates bullish tone to continue.* We recommend creating fresh longs in the mentioned range.Buy Glenmark Pharmaceuticals Ltd CMP 861.90; Range 860-864; SL 835; Target 920Please refer disclaimer at?https://www.religareonline.com/disclaimerSEBI Re...
Stock of the day : Buy Glenmark Pharmaceuticals For Target Rs. 920 - Religare Broking Ltd
Glenmark Pharmaceuticals is currently trading at Rs. 813.35, up by 2.55 points or 0.31% from its previous closing of Rs. 810.80 on the BSE.The scrip opened at Rs. 811.05 and has touched a high and low of Rs. 819.85 and Rs. 788.60 respectively. So far 52046 shares were traded on the counter.The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 836.30 on 09-Aug-2023 and a 52 week low of Rs. 363.80 on 27-Sep-2022.Last one week high and low of the scrip stood at Rs. 819.85...
Glenmark Pharmaceuticals inches up on aiming to grow revenues by 10-11% in FY24
Load More
